Dendritic cell maturity and obstructive airway disease by Demedts, Ingel et al.
Correspondence
Dendritic Cell Maturity and Obstructive
Airway Disease
To the Editor:
We read with interest the article by Demedts and colleagues, who
evaluated, by immunohistochemistry, the increased infiltration
of small airways by dendritic cells (DCs) in chronic obstructive
pulmonary disease (COPD) (1). In asthma, we have reported a
decrease in the number of mature DCs (mDCs) in endobronchial
biopsies of current smokers by comparisonwith never-smokers (2).
Also, we have unpublished data showing that the bronchialmucosa
of patients with COPD has fewer mDCs than normal healthy
nonsmoker controls and that current smokers have significantly
fewer sputummDCsthanex-smokerswithorwithoutCOPD.What
might be a possible explanation for these apparent differences?
The identification of the distinct immunophenotypes of DCs
depends on the method applied. Fluorescence activated cell sorter
(FACS)analysisof cells isolated from lungdigests,bronchoalveolar
lavage fluid, or sputum allows identification of Langerhans’ cells
(LCs), myeloid DCs types 1 and 2, and plasmacytoid DCs, and
distinguishes between mDCs and immature DCs (iDCs). In tissue,
immunohistochemistry can identify LCs (CD1a1, Langerin1) and
mDCs(CD831),butotherDCphenotypesarenotdetectedreliably
in paraffin wax–embedded material. Demedts and colleagues
applied an antibody directed against Langerin and thus provide
interesting data on the increased numbers of LCs, an important
subset of DCs, but their article does not address changes in the
numbers of mDCs. Moreover, the LCs that stained positively for
Langerin were most likely immature, as Langerin expression is
down-regulated upon maturation.
Interestingly, cigarette smoke has been shown in vitro to
suppress DC maturation (3), and incubation of LPS-matured
DCs with sputum from patients with COPD decreases expres-
sion of costimulatory molecules on mDCs and inhibits DC
maturation (4). Thus, DC maturation is likely attenuated in
healthy smokers and in smokers with obstructive airway disease.
The reciprocal of this may be an increase in the numbers of
iDCs reported by Demedts and coworkers (1).
Finally, decreasedDCmaturationmay shift theCD41/CD81T-
cell ratio in the lungs toward CD81 cells, as the time required
for DCs to launch the proliferative program for CD81 is less than
that required for CD41 cells (5). As the proliferative capacity of
CD81 cells is greater than that of CD41 cells, the latter are more
susceptible to the effects of reduced DC maturation (6). The
hypothesis that cigarette smoke–induced reduction of DCmatura-
tion is associated with development of the ‘‘abnormal’’ or exagger-
ated inflammation associated with smokers and COPD, or to
resistanceof asthmatic smokers to steroid therapy, shouldbe tested.
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From the Authors:
We read with great interest the letter by Tsoumakidou and
Jeffery regarding our article on the accumulation of dendritic
cells (DCs) in the small airways of patients with chronic
obstructive pulmonary disease (COPD) (1). They suggest that
DC maturation is attenuated in healthy smokers and in smokers
with obstructive airway disease. This hypothesis surely deserves
further attention, but our data do not allow confirmation of this
statement.
When comparing data from different studies, several meth-
odological issues need to be kept in mind. First, the site of sam-
pling might differ. Findings in large airways are not necessarily
the same as in small airways. Second, the study population
might be quite different in one study compared with another.
The effects of cigarette smoke on DC maturation might be
different in asthmatics when compared with patients with COPD
or healthy controls. Third, differences in the use of markers to
study DCs are of great importance. Both CD1a and Langerin are
markers for immature DCs. In the study by Tsoumakidou and
colleagues, there was no effect of cigarette smoking on the
number of CD1a1DCs in bronchial epithelium (2), findings that
are consistent with our data obtained in patients with COPD.
CD83 is often used as a marker for mature DCs, but several
groups reported the expression of CD83 on B lymphocytes and
Langerhans’ cells (3). Immunohistochemical studies using CD83
as a single marker to identify mature DCs should be interpreted
with caution. CD208may be a bettermarker to studymatureDCs
by immunohistochemistry (4).
There are currently no data that allow a conclusion on the
effect of cigarette smoke on DC maturation in small airways of
patients with COPD. Future cross-sectional studies should be
undertaken to investigate the effect of cigarette smoking on
both immature and mature DC numbers in healthy controls,
patients with COPD, and asthmatics. The subjects in these
studies should be carefully matched regarding age, severity of
disease, site of sampling, and treatment. Finally, it would be
especially useful to start longitudinal studies in which the number
of DCs could be evaluated before and after quitting smoking.
While this is not possible on tissue sections from surgical speci-
mens, it should be possible to perform these studies using serial
bronchial biopsies.
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Is Giant Cell Interstitial Pneumonitis Synonymous
with Hard Metal Lung Disease?
To the Editor:
The large case series of hard metal disease described byMoriyami
and colleagues in their article provides an important source of
clinico-pathologic data pertaining to a rare, but important inter-
stitial lung disease (1). The implications of the authors’ reported
observations from an immunological perspective were highlighted
in the erudite editorial by Nemery andAbraham in the same issue
(2). There were, however, important epidemiologic inferences to
be drawn from this report that are also worthy of comment.
The authors used electron probe microanalysis to assess the
elemental content in lung biopsy material from 85 patients with
interstitial lung disease ‘‘suspected to be of environmental or
occupational origin.’’ Although 23 of the 85 biopsies studied
(27%) manifest pathologic findings of giant cell interstitial
pneumonitis (GIP), the basis for study inclusion (i.e., etiological
suspicion of an occupational disease) is not elucidated and may
very well have included such histology as one criterion. This
would be a reasonable approach, given that GIP has come to be
treated as a pathologic finding wholly attributable to hard metal
or related cobalt-containing exposures. Indeed, this was the
stated rationale for ‘‘delisting’’ GIP as an ‘‘idiopathic’’ pneumo-
nia in the 2002 American Thoracic Society/European Respira-
tory Society (ATS/ERS) statement on the classification of
idiopathic interstitial pneumonias (3).
In that light, the further epidemiologic observation of Mor-
iyama and colleagues is all the more intriguing: of the 23 patients
with GIP, 2 (8.7%) had no occupational history of exposure (one
was a schoolteacher) and no tungsten or cobalt detectable by
probe analysis. A recent case report from India of an office
sweeper with GIP but no suspect history also raises the question
as towhether sporadic cases of this condition occur that cannot be
equated with hard metal lung disease (4). There certainly have
been cases of GIP in which an occupational history was atypical,
but where metals analysis indicated likely occult cobalt exposure
(5). Conversely, a thorough metal analysis can be negative, but
nonetheless the occupational or environmental history may be
highly suspect, as in the case of a 15-year-old with GIP both of
whose parents had occupational exposure to hard metal (6).
Nemery and Abraham argue cogently that we need to fill in our
knowledge gaps about hardmetal lung disease (2).Until we do so,
it may have been premature to banish GIP from the schema of
‘‘idiopathic interstitial pneumonias,’’ as was done in the ATS/
ERS statement (3).
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From the Authors:
We appreciate Dr. Blanc’s comments on our article (1). We
screened 85 biopsies; tungsten was detected in surgical biopsies
from 17 patients and in transbronchial biopsies (TBBs) from
three additional patients. Three TBBs were excluded from our
study because the pathologists could not make an accurate
pathologic diagnosis due to the small size of the TBB. A TBB
from an office sweeper without an exposure history was patho-
logically diagnosed as giant cell interstitial pneumonia (GIP)
(2), but we did not include TBB cases. Even though pathologists
find giant cells when screening biopsies, they should be careful
in making a final diagnosis of GIP, because giant cells are found
in other diseases such as viral pneumonia, especially pneumonia
due to measles, and sarcoidosis.
We applied an improved technique for element analysis of
tissue sections using an electron probe microanalyzer (EPMA)
with a wavelength dispersive spectrometer (WDS) (1). This
technique has about 10 times higher sensitivity than EPMA with
an energy dispersive spectrometer and enabled us to detect
tungsten in lung tissue in which the element was not found by the
other method (unpublished data; Reference 3). We found two
biopsies exhibiting featuresofGIPwithneither tungstennor cobalt
detected in the lung tissuebyEPMA-WDSnoraworkinghistory in
the hard metal industry. Finally, 2 (10.5%) of 19 surgical lung
biopsies were thought to be ‘‘idiopathic’’ GIP in our case series.
In addition to EPMA, atomic absorption spectrometry, plasma
optical emission mass spectrometry, and ionic coupled plasma
emission spectrometry have been used to detect tungsten and
cobalt in lung tissue (2, 4, 5).All of these techniques aremethods to
detect elements in dissolved tissue solution. Using these methods,
one cannot see the relationship between elements and the charac-
teristic lesions ofGIP, including centrilobular fibrosis andgiant cell
accumulation within alveolar space; thus, some GIP diagnosed as
hard metal lung disease might actually be ‘‘idiopathic’’ GIP.
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